Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors

被引:7
作者
Cai, Yibo [1 ]
Liu, Zhuo [1 ]
Jiang, Lai [1 ]
Ma, Dening [1 ]
Zhou, Zhenyuan [1 ]
Ju, Haixing [1 ]
Zhu, Yuping [1 ]
机构
[1] Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp,Univ Chinese Acad Sci, Inst Basic Med & Canc IBMC,Dept Colerectal Surg, Hangzhou, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词
gastroenteropancreatic neuroendocrine tumors; small tumor size; lymph node metastatic patterns; surgical strategy; SEER database; CONSENSUS GUIDELINES UPDATE; MANAGEMENT; CARCINOIDS; SURVIVAL; PROGNOSIS; NEOPLASMS; SURGERY; SIZE;
D O I
10.3389/fendo.2022.871830
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundRegional lymph node metastasis (LNM) is crucial for planning additional lymphadenectomy, and is directly correlated with poor prognosis in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). However, the patterns of LNM for small (<= 20 mm) GEP-NETs remain unclear. This population-based study aimed at evaluating LNM patterns and identifying optimal surgical strategies from the standpoint of lymph node dissemination. MethodsThis retrospective cohort study retrieved data from the Surveillance, Epidemiology, and End Results (SEER) 18 registries database for 17,308 patients diagnosed as having localized well-differentiated GEP-NETs <= 20 mm between January 1, 2004, and December 31, 2017. The patterns of LNM were characterized in 6,622 patients who underwent extended resection for adequate lymph node harvest. ResultsOf 6,622 patients with localized small GEP-NETs in the current study, 2,380 (36%) presented with LNM after regional lymphadenectomy. Nodal involvement was observed in approximately 7.4%, 49.1%, 13.6%, 53.7%, 13.8%, 7.8%, and 15.4% of gastric (g-), small intestinal (si-), appendiceal (a-), colonic (c-), rectal (r-), non-functional pancreatic (nfp-), and functional pancreatic (fp-) NETs <= 20 mm. Patients with younger age, larger tumor size, and muscularis invasion were more likely to present with LNM. Additional lymphadenectomy conferred a significant survival advantage in NETs (<= 10 mm: HR, 0.47; 95% CI, 0.33-0.66; p < 0.001; 11-20 mm: HR, 0.54; 95% CI, 0.34-0.85; p = 0.008) and fp-NETs <= 20 mm (HR, 0.08; 95% CI, 0.02-0.36; p = 0.001), as well as g-NETs (HR, 0.39; 95% CI, 0.16-0.96; p = 0.041) and c-NETs of 11-20 mm (HR, 0.07; 95% CI, 0.01-0.48; p = 0.007). Survival benefits of additional lymphadenectomy were not found in a-NETs, r-NETs, and nfp-NETs with a small size. ConclusionsGiven the increased risk for nodal metastasis, primary tumor resection with regional lymphadenectomy is a potential optimal surgical strategy for si-NETs and fp-NETs <= 20 mm, as well as g-NETs and c-NETs of 11-20 mm. Local resection is an appropriate and reliable surgical approach for a-NETs, r-NETs, and nfp-NETs <= 20 mm.
引用
收藏
页数:9
相关论文
共 41 条
[1]   Tumor Size and Depth Predict Rate of Lymph Node Metastasis in Colon Carcinoids and Can Be Used to Select Patients for Endoscopic Resection [J].
Al Natour, Riad H. ;
Saund, Mandeep S. ;
Sanchez, Vivian M. ;
Whang, Edward E. ;
Sharma, Ashish M. ;
Huang, Qin ;
Boosalis, Valia A. ;
Gold, Jason S. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (03) :595-602
[2]  
[Anonymous], 2017, NCCN Clinical Practice Guidelines in Oncology: Distress Management, DOI DOI 10.6004/JNCCN.2021.0007
[3]   Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors [J].
Blakely, Andrew M. ;
Lafaro, Kelly J. ;
Li, Daneng ;
Kessler, Jonathan ;
Chang, Sue ;
Ituarte, Philip H. G. ;
Lee, Byrne ;
Singh, Gagandeep .
NEUROENDOCRINOLOGY, 2020, 110 (05) :384-392
[4]   Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors [J].
Blakely, Andrew M. ;
Raoof, Mustafa ;
Ituarte, Philip H. G. ;
Fong, Yuman ;
Singh, Gagandeep ;
Lee, Byrne .
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (12) :4008-4015
[5]   Gastroenteropancreatic Neuroendocrine Tumors [J].
Cives, Mauro ;
Strosberg, Jonathan R. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :471-487
[6]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342
[7]   The risk of lymph node metastases and their impact on survival in patients with appendiceal neuroendocrine neoplasms: a systematic review and meta-analysis of adult and paediatric patients [J].
Daskalakis, Kosmas ;
Alexandraki, Krystallenia ;
Kassi, Evanthia ;
Tsoli, Marina ;
Angelousi, Anna ;
Ragkousi, Athanasia ;
Kaltsas, Gregory .
ENDOCRINE, 2020, 67 (01) :20-34
[8]   Updating the management of patients with rectal neuroendocrine tumors [J].
de Mestier, Louis ;
Brixi, Hedia ;
Gincul, Rodica ;
Ponchon, Thierry ;
Cadiot, Guillaume .
ENDOSCOPY, 2013, 45 (12) :1039-1046
[9]   ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms [J].
Delle Fave, G. ;
O'Toole, D. ;
Sundin, A. ;
Taal, B. ;
Ferolla, P. ;
Ramage, J. K. ;
Ferone, D. ;
Ito, T. ;
Weber, W. ;
Zheng-Pei, Z. ;
De Herder, W. W. ;
Pascher, A. ;
Ruszniewski, P. .
NEUROENDOCRINOLOGY, 2016, 103 (02) :119-124
[10]   ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors [J].
Falconi, M. ;
Eriksson, B. ;
Kaltsas, G. ;
Bartsch, D. K. ;
Capdevila, J. ;
Caplin, M. ;
Kos-Kudla, B. ;
Kwekkeboom, D. ;
Rindi, G. ;
Kloeppel, G. ;
Reed, N. ;
Kianmanesh, R. ;
Jensen, R. T. .
NEUROENDOCRINOLOGY, 2016, 103 (02) :153-171